Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Revista española de enfermedades digestivas 2010-10, Vol.102 (10), p.614-616
Hauptverfasser:	Ramos, J M, García-Sepulcre, M F, Masiá, M, Brotons, A, Grau, M C, Gutiérrez, F
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Inflammatory Agents - adverse effects Anti-Inflammatory Agents - therapeutic use Anti-Inflammatory Agents, Non-Steroidal - adverse effects Anti-Inflammatory Agents, Non-Steroidal - therapeutic use Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Azathioprine - adverse effects Azathioprine - therapeutic use Crohn Disease - complications Female Gastroenterology & Hepatology Geriatrics & Gerontology Humans Immunosuppressive Agents - adverse effects Immunosuppressive Agents - therapeutic use Infectious Diseases Inflammatory Bowel Diseases - complications Inflammatory Bowel Diseases - drug therapy Infliximab Listeriosis - etiology Mesalamine - adverse effects Mesalamine - therapeutic use Middle Aged Oncology Pathology Pharmacology & Pharmacy Radiology, Nuclear Medicine & Medical Imaging Surgery Tumor Necrosis Factor-alpha - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!